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a b s t r a c t
Claudins are transmembrane proteins that play a role in cell proliferation and adhesion and
tumourigenesis. This study evaluated the immunoexpression of claudin-1 in the oral
epithelial dysplasia (OED) (19 mild, 26 moderate, 3 severe). Diffuse staining predominated
in mild (89.4%) and moderate (80.8%) OEDs. Immunoexpression in the middle and upper
third was observed in all mild cases, whereas in moderate/severe dysplasias staining was
observed in the upper third in 41.4% of cases, in the upper and middle third in 41.4%, and in
the upper, middle and lower third in 17.2% (P < 0.05). All mild OEDs and 73.1% of moderate
cases presented only membrane staining, whereas membrane/cytoplasmic staining was
observed in severe cases. Staining intensity was weak in 60% of parakeratinized OEDs and
moderate/strong in orthokeratinized OEDs (60.8%) (P > 0.05). The differences in the immu-
noexpression of claudin-1 between different grades of OEDs suggest the involvement of this
protein in the progression of dysplasias.
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available at www.sciencedirect.com
journal homepage: http://www.elsevier.com/locate/aob1. Introduction
The intercellular junctional complexes are important struc-
tures in the architecture and physiological function of tissues
of multicellular organisms. There are three main types of
intercellular junctions: tight junctions, adherent junctions,
and gap junctions.1–3 Tight junctions are proteins located in
the apical portion of the junctional complex, which form a belt
around the cell.3,4 These junctions are found in various
epithelial tissues, including stratified squamous epithelium.5
Tight junctions are involved in mechanisms that regulate
transcription, proliferation and cell polarity, in addition to
forming a diffusion barrier.1,6,7
Tight junctions consist of peripheral and transmembrane
proteins.8 The transmembrane proteins can be divided into
three types: occludins, junctional adhesion molecules, and
claudins.4,9 Claudins are considered to be the main tight* Corresponding author at: Universidade Federal do Rio Grande do Nor
Lagoa Nova, Natal, RN, CEP 59056-000, Brazil. Tel.: +55 84 3215 4138; f
E-mail address: mccmiguel@hotmail.com (M.C.da.C. Miguel).
0003–9969/$ – see front matter # 2010 Elsevier Ltd. All rights reserve
doi:10.1016/j.archoralbio.2010.02.001junction-forming proteins.8,10 These proteins comprise a
family of 24 members and claudin-1 has been shown to be
essential for the function of tight junctions.2,6
Claudins have been associated with the pathogenesis of
neoplastic processes, since alterations in these structures may
lead to increased nutrient diffusion and influence other
factors that promote the development of tumours such as
human carcinomas.10,11 Biochemical and molecular changes
in cells precede the establishment of cancer, and the
dysregulation of different proteins might be involved in this
process. Amongst these proteins there are claudins, which
influence diverse cell functions.
Immunoreactivity for claudins can be seen in different
potentially malignant lesions and carcinomas. There are,
however, tissue type-specific differences in their expression.
Investigators have showed the overexpression of these
proteins in epithelial dysplasias,5,12 cervical intraepithelialte, Departamento de Odontologia, Av. Senador Salgado Filho, 1787
ax: +55 84 3215 4138.
d.
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showed low expression in skin carcinoma,18 oesophageal
carcinoma,17–21 colon carcinoma,19,22,23 breast cancer,19,24,25
gastric carcinoma,26 and prostate cancer.27 Besides, cytoplas-
matic and nuclear mislocalization were observed in oesopha-
geal21 and colon23 carcinomas, respectively.
A potential mechanism by which alterations in the
expression of claudins may contribute to oral carcinogenesis
is through destabilization of tight junctions, resulting in loss of
adhesion properties, known to be involved in early steps of
invasion and metastasis.5 Few studies have investigated the
expression of claudins in oral potentially malignant lesions,
especially oral epithelial dysplasias (OEDs). Therefore, the
objective of the present study was to evaluate the immuno-
histochemical expression of claudin-1 in different grades of
OED in order to determine whether a relationship exists
between the expression of this protein and oral epithelial
alterations that occur during the development of dysplasia.
2. Materials and methods
Forty-eight OED specimens fixed in 10% formaldehyde and
embedded in paraffin were obtained from the archives of the
Discipline of Oral Pathology, Department of Dentistry, Federal
University of Rio Grande do Norte. Haematoxylin-eosin-
stained sections (5 mm) were used for morphological analysis.
The classification criteria of the World Health Organization
were used for the definition of the different grades of OED
(Table 1).28
Histological sections (3 mm thick) were submitted to
immunohistochemistry by the streptavidin-biotin method.
Antigen retrieval was performed with citrate, pH 6.0, in a
microwave for 10 min. The specimens were incubated with
anti-claudin-1 (clone JAY.8, ZYMED, South San Francisco, CA),
diluted 1:50, as primary antibody for 60 min.
The immunohistochemical expression of claudin-1 in the
different grades of OED was analyzed considering distribution,
epithelial localization, cellular localization and intensity of
staining. The staining distribution was classified into focal
(30% of the epithelium) and diffuse (>30% of the epithelium),Table 1 – Criteria used for diagnosing grades of oral
epithelial dysplasias (WHO, 2005).
Grades of OED Criteria of grades of OED
Mild dysplasia Architectural disturbance limited to the
lower third of the epithelium accompanied
by minimal cytological atypia.
Moderate dysplasia Architectural disturbance extending into
the middle third of the epithelium
accompanied by cytological atypia.
Severe dysplasia Architectural disturbance with greater
than two thirds of the epithelium showing
architectural disturbance with associated
cytological atypia. However, architectural
disturbance extending into the middle
third of the epithelium with sufficient
cytological atypia is upgraded from
moderate to severe dysplasia.adapted from Sheehan et al.27 Epithelial localization, i.e., the
predominant site of immunohistochemical expression in the
epithelium, was divided into upper, middle and lower third
according to the criteria of Usami.20 Cellular localization,
corresponding to the site of expression in the cell, was
classified as membrane or membrane/cytoplasmic staining,
adapted from Sobel et al.13 Staining intensity, corresponding
to the degree of immunohistochemical expression of claudin-
1 in the specimens selected, was evaluated subjectively on a
qualitative scale and was defined as weak, moderate or
strong.27 For statistical analysis, moderate staining was
analyzed together with strong staining when staining inten-
sity was correlated with the keratinization type of the
epithelium and grade of OED. Similarly, moderate and severe
OEDs were analyzed together when the grade of OED was
correlated with epithelial localization and staining intensity.
Epithelium of normal oral mucosa, obtained from cosmetic
surgery, was used as positive control. All assessments were
independently performed by two previously calibrated obser-
vers and were then compared until a consensus was reached.
Descriptive statistics and Pearson’s Chi-square test were
used for analysis of the results using the Statistical Package for
the Social Sciences, version 17.0 (SPSS, Chicago, IL). A P value
<0.05 was considered to indicate statistical significance.
The study was approved by the Ethics Committee of the
Federal University of Rio Grande do Norte, Brazil (protocol 036/
2009).
3. Results
The sample consisted of 48 cases of OED, including 19 (39.6%)
mild cases, 26 (54.2%) moderate cases, and 3 (6.3%) severe
cases, defined according to the 2005 classification criteria of
the World Health Organization.28
With respect to distribution, staining was focal in 10.5% of
mild dysplasia cases and diffuse in 89.4%. In moderate
dysplasias, focal staining was observed in 19.2% of cases
and diffuse staining in 80.8%. Focal staining predominated in
severe dysplasias (66.7%), whereas diffuse staining was
observed in 33.3% of these cases.Fig. 1 – Immunohistochemical expression claudin-1 in the
middle and upper third in mild OED (SABC, 400T).
Table 2 – Correlation between the grades of OED and epithelial localization of the immunohistochemical expression of
claudin-1.
Grades of OED Epithelial localization
Upper third n (%) Upper and middle
third n (%)
Upper, middle and
lower third n (%)
Total n (%)
Mild n (%) 0 (0) 19 (100.0) 0 (0) 19 (100.0)
Moderate/severe n (%) 12 (41.4) 12 (41.4) 5 (17.2) 29 (100.0)
Total n (%) 12 (25.0) 31 (64.6) 5 (10.4) 48 (100.0)
Chi-square test (P < 0.05).
Table 3 – Correlation between the grades of OED and cellular localization of the immunohistochemical expression of
claudin-1.
Grades of OED Cellular localization
Membrane n (%) Membrane/cytoplasm n (%) Total n (%)
Mild n (%) 19 (100.0) 0 (0) 19 (100.0)
Moderate n (%) 19 (73.1) 10 (26.9) 26 (100.0)
Severe n (%) 0 (0) 3 (100.0) 3 (100.0)
Total n (%) 38 (79.1%) 10 (20.8%) 48 (100.0)
Chi-square test (P < 0.05).
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sion of claudin-1 in the middle and upper third in all mild OED
cases (100%) (Fig. 1). In contrast, in moderate/severe dysplasias
staining was only observed in the upper third in 41.4% of cases,
in the upper and middle third in 41.4%, and in the upper,
middle and lower third in 17.2% (P < 0.05) (Table 2).Fig. 2 – Membrane and cytoplasmic staining of claudin-1 in
severe OED (SABC, 400T).
Table 4 – Correlation between the keratinization type and inte
Keratinization type
Weak n (%)
Parakeratinized n (%) 15 (60.0)
Orthokeratinized n (%) 9 (39.2)
Total n (%) 24 (50.0)
Chi-square test (P > 0.05).All mild OED cases (100%) and 73.1% of moderate cases
presented only membrane staining, whereas membrane/
cytoplasmic staining was observed in all severe OED cases
(100%) (Table 3; Fig. 2).Fig. 3 – Differentiates in the intensity of the expression of
claudin-1 in parakeratinized and orthokeratinized
epithelium (SABC, 200T).
nsity of expression of the claudin-1.
Intensity of expression
Moderate/strong n (%) Total n (%)
10 (40.0) 25 (100.0)
14 (60.8) 23 (100.0)
24 (50.0) 48 (100.0)
Table 5 – Correlation between the grades of OED and intensity of expression of the claudin-1.
Grades of OED Intensity of expression
Weak n (%) Moderate/strong n (%) Total n (%)
Mild n (%) 10 (52.6) 9 (47.4) 19 (100.0)
Moderate/severe n (%) 14 (48.3) 15 (51.7) 29 (100.0)
Total n (%) 24 (50.0) 24 (50.0) 48 (100.0)
Chi-square test (P > 0.05).
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parakeratinized stratum corneum (60%), whereas moderate/
strong staining was more frequent in orthokeratinized OEDs
(60.8%) (P > 0.05) (Table 4; Fig. 3).
Overall analysis of staining intensity showed weak staining
in half the cases (50%), moderate staining in 41.7%, and strong
staining in 8.3%. No significant correlation was observed
between staining intensity and OED grade, with staining being
weak in 52.6% of mild OED cases and strong in 51.7% of
moderate/severe cases (P > 0.05) (Table 5; Fig. 4).
4. Discussion
Cell–cell adhesion is generally altered in cancer, a fact
resulting in cell dissemination, invasion of neighboring
structures and metastasis.5,8,13 The expression of claudins is
dysregulated in a series of conditions such as potentially
malignant lesions and malignant neoplasms as demonstrated
by the overexpression, loss of expression and reduced
expression of these proteins in different diseases.5,29,30
In the present study, moderate dysplasia was the predomi-
nant grade, followed by mild and severe dysplasia. Lee et al.31
evaluating the prevalence of oral leukoplakia, identified OEDs
in 45.6% of cases, including mild dysplasia in 42%, moderate
dysplasia in 49% and severe dysplasia in 9%. In a study
investigating the clinical presentation of epithelial dysplasias
in 630 patients, Jaber et al.32 observed a frequency of 41.7% of
mild OED, 29% of moderate dysplasia and 23.8% of severe
dysplasia. These results indicate a low prevalence of severe
grade OEDs, in agreement with the present study, and
alternation in the number of moderate and mild cases.Fig. 4 – Strong immunohistochemical expression the
claudin-1 in moderate OED (SABC, 400T).Few studies have examined the risk of malignant transfor-
mation of different grades of OEDs. However, it has been
suggested that the grade of dysplasia may guide the adequate
treatment of these potentially malignant lesions.33 A study
involving Irish patients evaluated the potential of malignant
transformation of oral mucosa white lesions and development
of previously dysplastic lesions into malignant neoplasms was
observed in 15% of cases.34 Lee et al.35 observed that moderate
and severe dysplasias possess a 2.3 times higher risk of
undergoing malignant transformation than mild dysplasias or
hyperplasias. Another study conducted on patients with oral
leukoplakia showed that cases of moderate or severe dysplasia
presented a higher risk of transformation into carcinomas
than mild dyplasias.36
In the present study, in cases of mild OED no immunoex-
pression of claudin-1 was detected in the lower third of the
epithelium. This finding might be explained by the lack of
constitutive expression of the protein in the basal cell layer of
normal oral mucosa as demonstrated by Dos Reis et al.5 In
addition, several studies have shown that claudins present in
tight junctions are mainly expressed in the upper layers of the
epidermis.6,37,38 Reduced expression of claudin-1 in the middle
third was observed in moderate and severe cases of OED.
These findings suggest that, in mild OEDs, the basal cell layer
maintains characteristics similar to those of normal oral
mucosa, and that more marked modifications, i.e., those
producing molecular changes detected immunohistochemi-
cally, start to arise only in moderate and severe grade OEDs.
Studies have demonstrated the loss or reduction of claudin
expression in both dysplasias and neoplasms. Arabzadeh
et al.17 induced tumourigenesis in the epidermis of rats and
observed the loss of expression of claudin-1, -6, -11, -12 and -18
in the basal and suprabasal layer with the progression of
carcinogenesis. Resnick et al.22 showed the loss of claudin-1
expression in colon cancer, which was strongly correlated
with recurrence and low patient survival. Kramer et al.24
reported the loss of claudin-1 expression in primary breast
tumours when compared to its expression in other human
tissues, suggesting that this protein is involved in the
development of breast cancer and, possibly, other epithelial
tumours. Reduced expression of claudin-7 in ductal breast
carcinoma was reported by Kominsky et al.25, probably
influencing cell dissemination and increasing the metastatic
potential of the tumour. According to these authors, hyper-
methylation of promotor sequences in the claudin-7 gene is
the main mechanism responsible for the reduced expression
of this protein.
The loss or reduction of claudin-7 expression was also
demonstrated in oesophageal squamous cell carcinoma and
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tumour.20 Al Moustafa et al.39 compared cDNA microarrays
between normal epithelium and head and neck squamous cell
carcinoma and found down-regulation of claudin-7 gene
expression in neoplastic cells. Sheehan et al.27 observed
reduced expression of claudin-1 and -7 in prostate adeno-
carcinomas when compared to adjacent normal tissue areas,
which was correlated with a more aggressive behaviour of the
tumour. These findings agree with the view that the loss or
reduction of expression of these proteins is involved in the
mechanism of carcinogenesis. In the case of OEDs, this
reduced expression in dysplastic areas might be associated
with the onset of alterations within the cellular environment
that result in the malignant transformation of epithelial tissue
observed in some OEDs.
On the other hand, various studies have demonstrated the
overexpression of claudins in different neoplasms and
potentially malignant lesions. Dos Reis et al.5 observed an
increased expression of claudin-1 in oral squamous cell
carcinomas, especially those presenting perineural and
angiolymphatic invasion, and correlated this increase with
the aggressive behaviour of the tumour. Strong staining for
this protein in the lower third of the epithelium was also
observed in adjacent dysplastic areas. Increased expression of
claudin-1 and -7 was also found in squamous cell carcinomas
of the tongue and was associated with reduced patient
survival.15 A recent study on cervical squamous cell carcino-
mas cited an increase in the expression of claudin-1 and -7 as
one of the initial changes that occur during the progression
and malignant transformation of normal cervical squamous
cells.14 In cervical intraepithelial neoplasia, high expression of
claudin-1 was strongly associated with the initial phases of
carcinogenesis and may serve as an important diagnostic
marker for this type of tumour.13 According to Resnick et al.22
the increased expression of claudins suggests that their
aberrant form may directly interfere with the structure and
function of tight junctions, resulting in significant disorgani-
zation and increased cell permeability, and thus contribute to
the development of cancer.
The reason for the discrepancy observed in the expression
of claudins between different types of lesions is still unclear,
but might be related to differences in the function of these
proteins in each tissue or even to the specific characteristics of
the tissue microenvironment.10
Membrane expression of claudin-1 was observed in all OED
cases. However, additional cytoplasmic staining was found in
all cases of severe OED and in about 1/3 of moderate cases. The
cytoplasmic localization of claudins might be related to the
loss of function of these proteins, resulting from different
mechanisms such as protein phosphorylation.17,40–42 Some
studies associated the cytoplasmic localization of tight
junctions with tumour progression. Investigating colon
carcinoma, Dhawan et al.23 observed an increased expression
and translocation of claudin-1 to the cytoplasm in neoplastic
cells. The degree of translocation was higher when expression
was analyzed in metastatic neoplastic cells. Arabzadeh et al.17
showed translocation of claudin-6, -11, -12 and -18 to the
cytoplasm with the progression of carcinogenesis in the
epidermis of rats. Lioni et al.21 demonstrated that in the
normal human oesophagus expression of claudin-4 and -7 isconfined to the cell membrane of differentiated keratinocytes,
whereas in oesophageal squamous cell carcinoma the
expression of these proteins is translocated to the cytoplasm.
This suggests that the presence of claudin in the cytoplasm
has some function in intracellular signaling, which may play
an important role in the progression of OEDs, since cyto-
plasmic expression was observed in more severe degrees.
However, this mechanism is still unclear.
According to Ivanov et al.41, translocation of tight junctions
present in the cell membrane to the cytoplasm might also be
related to the internalization (endocytosis) of these proteins
and consequent loss or reduction of their function. However,
studies investigating the involvement of tight junctions in this
process are scarce. Several studies have focused on the
mechanism of endocytosis of adherent junctions, such as E-
cadherins, which seems to play an important role in the
development and metastasis of different cancers.43 Internali-
zation of these proteins, as well as of tight junctions, has been
shown to occur in response to physiological and pathological
processes.41 Pathological stimuli such as cytokines, growth
factors, oxidative stress and bacterial and viral toxins have
been indicated as factors that stimulate endocytosis.41,44,45 On
the basis of these studies, the translocation of claudin-1 to the
cytoplasm observed in the present investigation may also be
related to internalization of this protein in moderate and
severe cases of OED, promoting the down-regulation of this
protein.
Yuki et al.6 and Yamamoto et al.37 showed that tight
junctions are mainly present in the granular layer of the
epidermis, thus playing an important role as an epithelial
barrier. Yoshida et al.46 reported the expression of occludins
only in the granular cell layer of the epidermis, and Furuse
et al.38 demonstrated that claudin-1 and -4 are also concen-
trated in this layer. These findings agree with the present
results and support the view that claudin-1 plays a funda-
mental role in the upper portions of epithelial tissue,
especially in the granular cell layer.
Since the recent discovery of claudins, numerous studies
have demonstrated the loss, reduction or increase of expression
of these proteins in various types of cancer, findings indicating
their involvement in tumourigenesis. Thus, these proteins
might be a promising target in studies investigating both the
diagnosis and prognosis of cancer and cancer therapy.
Furthermore, the alterations in the immunoexpression of
claudin-1 observed between different grades of OEDs suggest
that this protein might be involved in the progression of
dysplasias that may culminate in the malignant transforma-
tion of the epithelium. However, as the present work is not a
prospective study, it cannot evaluate the potential for
malignant transformation of OED. In addition, Smith et al.47
report other significant potential sources of bias, such as the
lack of analysis of the effect of environmental risk factors and
method of biopsy (incisional vs. excisional), and results of
retrospective, single centre, observational studies.
Thus, further long-term outcome studies, in which follow-
up data were recorded, and a large number of cases, with
multi-centre collaboration, are necessary to determine the
specific mechanism underlying this event. Although our work
does not overcome these problems, it can serve as guide for
future prospective well-designed studies.
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